Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZC6X
|
|||
| Former ID |
DNCL001677
|
|||
| Drug Name |
PRTX-100
|
|||
| Synonyms |
Staphylococcal protein A
Click to Show/Hide
|
|||
| Indication | Arthritis [ICD-11: FA20; ICD-9: 714] | Phase 1/2 | [1] | |
| Behcet disease [ICD-11: 4A62; ICD-10: M35.2; ICD-9: 136.1] | Phase 1/2 | [2] | ||
| Rheumatoid arthritis [ICD-11: FA20] | Phase 1/2 | [3] | ||
| Thrombocytopenia [ICD-11: 3B64] | Phase 1/2 | [3] | ||
| Company |
Protalex
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02401061) Open-Label, Dose Escalation Study of PRTX-100 in Adults With Persistent/Chronic Immune Thrombocytopenia. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.